Lexeo Therapeutics, Common Stock Market Value
| LXEO Stock | 5.25 0.43 7.57% |
| Symbol | Lexeo |
Lexeo Therapeutics, Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lexeo Therapeutics,. If investors know Lexeo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lexeo Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Lexeo Therapeutics, is measured differently than its book value, which is the value of Lexeo that is recorded on the company's balance sheet. Investors also form their own opinion of Lexeo Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Lexeo Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lexeo Therapeutics,'s market value can be influenced by many factors that don't directly affect Lexeo Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lexeo Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Lexeo Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lexeo Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Lexeo Therapeutics, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lexeo Therapeutics,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lexeo Therapeutics,.
| 11/01/2024 |
| 01/30/2025 |
If you would invest 0.00 in Lexeo Therapeutics, on November 1, 2024 and sell it all today you would earn a total of 0.00 from holding Lexeo Therapeutics, Common or generate 0.0% return on investment in Lexeo Therapeutics, over 90 days. Lexeo Therapeutics, is related to or competes with Autohome, Integrated Media, Flutter Entertainment, HomeStreet, BRP, Invitation Homes, and Taylor Morn. Lexeo Therapeutics, is entity of United States More
Lexeo Therapeutics, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lexeo Therapeutics,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lexeo Therapeutics, Common upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 24.35 | |||
| Value At Risk | (9.77) | |||
| Potential Upside | 8.65 |
Lexeo Therapeutics, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lexeo Therapeutics,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lexeo Therapeutics,'s standard deviation. In reality, there are many statistical measures that can use Lexeo Therapeutics, historical prices to predict the future Lexeo Therapeutics,'s volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.66) | |||
| Total Risk Alpha | (1.33) | |||
| Treynor Ratio | 1.5 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lexeo Therapeutics,'s price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lexeo Therapeutics, Backtested Returns
Lexeo Therapeutics, has Sharpe Ratio of -0.091, which conveys that the firm had a -0.091 % return per unit of risk over the last 3 months. Lexeo Therapeutics, exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Lexeo Therapeutics,'s Mean Deviation of 4.44, standard deviation of 5.84, and Risk Adjusted Performance of (0.09) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -0.47, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Lexeo Therapeutics, are expected to decrease at a much lower rate. During the bear market, Lexeo Therapeutics, is likely to outperform the market. At this point, Lexeo Therapeutics, has a negative expected return of -0.52%. Please make sure to verify Lexeo Therapeutics,'s potential upside and rate of daily change , to decide if Lexeo Therapeutics, performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.3 |
Weak reverse predictability
Lexeo Therapeutics, Common has weak reverse predictability. Overlapping area represents the amount of predictability between Lexeo Therapeutics, time series from 1st of November 2024 to 16th of December 2024 and 16th of December 2024 to 30th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lexeo Therapeutics, price movement. The serial correlation of -0.3 indicates that nearly 30.0% of current Lexeo Therapeutics, price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.3 | |
| Spearman Rank Test | 0.25 | |
| Residual Average | 0.0 | |
| Price Variance | 0.52 |
Lexeo Therapeutics, lagged returns against current returns
Autocorrelation, which is Lexeo Therapeutics, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Lexeo Therapeutics,'s stock expected returns. We can calculate the autocorrelation of Lexeo Therapeutics, returns to help us make a trade decision. For example, suppose you find that Lexeo Therapeutics, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Lexeo Therapeutics, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Lexeo Therapeutics, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Lexeo Therapeutics, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Lexeo Therapeutics, stock over time.
Current vs Lagged Prices |
| Timeline |
Lexeo Therapeutics, Lagged Returns
When evaluating Lexeo Therapeutics,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Lexeo Therapeutics, stock have on its future price. Lexeo Therapeutics, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Lexeo Therapeutics, autocorrelation shows the relationship between Lexeo Therapeutics, stock current value and its past values and can show if there is a momentum factor associated with investing in Lexeo Therapeutics, Common.
Regressed Prices |
| Timeline |
Pair Trading with Lexeo Therapeutics,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lexeo Therapeutics, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lexeo Therapeutics, will appreciate offsetting losses from the drop in the long position's value.Moving together with Lexeo Stock
| 0.66 | JNJ | Johnson Johnson | PairCorr |
| 0.68 | LLY | Eli Lilly Earnings Call This Week | PairCorr |
| 0.64 | MRK | Merck Company Earnings Call This Week | PairCorr |
Moving against Lexeo Stock
| 0.67 | BMY | Bristol Myers Squibb Earnings Call This Week | PairCorr |
| 0.53 | MDGL | Madrigal Pharmaceuticals | PairCorr |
| 0.51 | MLAB | Mesa Laboratories Earnings Call This Week | PairCorr |
| 0.44 | GILD | Gilead Sciences Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Lexeo Therapeutics, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lexeo Therapeutics, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lexeo Therapeutics, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lexeo Therapeutics, Common to buy it.
The correlation of Lexeo Therapeutics, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lexeo Therapeutics, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lexeo Therapeutics, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lexeo Therapeutics, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Lexeo Therapeutics, Correlation, Lexeo Therapeutics, Volatility and Lexeo Therapeutics, Alpha and Beta module to complement your research on Lexeo Therapeutics,. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Lexeo Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.